TABLE 1.
Patient Characteristics
| Gemcitabine + Capecitabine | |
| No. Eligible Patients | 40 |
| Median patient age (range) | 61.3 yrs (36.0, 80.3) |
| No. Sex (%) | |
| Male | 32 (80) |
| Female | 8 (20) |
| No. Race (%) | |
| White | 36 (90) |
| African-American | 3 (7) |
| Native American | 1 (3) |
| No. Hispanic Origin (%) | |
| Yes | 1 (3) |
| No | 34 (85) |
| Unknown | 5 (12) |
| No. Performance Status (%) | |
| 0 | 17 (42) |
| 1 | 21 (53) |
| 2 | 2 (5) |
| No. Prior Therapy (%) | |
| Immunotherapy | 22 (55) |
| Nephrectomy | 30 (75) |
| Radiotherapy | 3 (7) |
| No. Tumor Histology (%) | |
| Clear Cell | 33 (82) |
| Papillary | 2 (5) |
| Adenocarcinoma | 1 (3) |
| Other (e.g. sarcomatoid) | 3 (7) |
| Unknown | 1 (3) |
| No. of Metastatic Sites (%) | |
| 1 | 6 (15) |
| 2 | 12 (30) |
| ≥3 | 22 (55) |